BioSpace News Archive

Brain Balance Achievement Centers, the leading integrative training program designed to improve brain connectivity and alleviate developmental and learning challenges, announced today the creation of its advisory board

A “decoy” mechanism has been found in human and animal cells to protect them from potentially dangerous toxins released by foreign invaders, such as bacteria.

LeMaitre Vascular, Inc. announced that it will be participating in three investor conferences in March..

Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that, as part of its overall capital financing strategy to fund the Company and the upcoming commercial launch of ANJESO™, it has signed a non-binding term sheet with an undisclosed party for a secured term loan for up to $20 million in non-dilutive funding over the next 12 to 18 months.

Carnahan Group, one of the nation’s leading healthcare advisory firms, held its annual Client Summit event for a diverse group of partners.

Colorado BioScience Association (CBSA) welcomes FDA’s Dr. Jeffrey Shuren via video conference to today’s annual Medical Device Symposium, to be held at the Westin in Westminster.

To help combat the Novel 2019 Coronavirus, the US Center for Disease Control (CDC) has recommended that citizens utilize EPA-Registered and Hospital Grade Disinfectant cleaners

International NGOs Lutheran World Relief and IMA World Health, building on their experience responding to Ebola in the Democratic Republic of Congo, are assisting local health networks in Africa to prepare for and respond to transmission of COVID-19, the coronavirus that originated in China in late 2019.

“Thirty-seven years after the discovery of HIV, the mechanism of AIDS-related immunosuppression was still poorly understood. Our discovery shows how the virus cooperates with the patients’ enzymes to disable lymphocytes and neutralize the immune response,” explained Prof. Jacques Thèze, co-founder and CEO of Diaccurate.

Today, Kenneth E. Thorpe, chairman of the Partnership to Fight Chronic Disease, issued the following statement regarding the coronavirus emergency funding package